Shares of Zydus Wellness Ltd (ZWL) jumped 3.56% to ₹2,090.50 in early trade on Monday after the company announced its first overseas acquisition, entering the global Vitamins, Minerals and Supplements (VMS) market.
On August 29, Zydus Wellness said its wholly owned subsidiary Alidac U.K. Limited signed a definitive agreement to acquire U.K.-based Comfort Click Limited (CCL) and its three subsidiaries in Ireland, the U.S., and India for GBP 239 million (₹2,846 crore), subject to customary adjustments under the terms of the Share Purchase Agreement.
Strategic significance
The acquisition marks Zydus Wellness’ foray into the international VMS space, diversifying its portfolio beyond India. CCL operates across the U.K. and Europe and is expanding into the U.S. market. It has a strong multi-segment presence, catering to adults, kids, and pets.
For the financial year ending June 30, 2025, CCL reported revenues of GBP 134 million, with a five-year CAGR of 57%, and an adjusted operating profit of GBP 21 million.
Company’s vision
Commenting on the acquisition, Sharvil Patel, Chairman of Zydus Wellness, said:
“The global acquisition of Comfort Click, a leading player in the digital vitamins, minerals and supplements space, marks a significant step in our journey to empower consumers to make informed choices and embrace wellness-focussed products as part of their path to better health.”
He added that the move strengthens Zydus’ global capabilities, deepens its presence in digital health and personalised wellness, and helps build scalable and sustainable business models for the future.
Market reaction
Alongside the acquisition, Zydus also announced the launch of a vaccine for a new strain of influenza virus, further boosting investor sentiment.
With this acquisition and product launch, Zydus Wellness has positioned itself as a forward-looking player in health and wellness, aiming to capture new markets while solidifying its domestic stronghold.
